SANGAMO THERAPEUTICS, INC Uncategorized Contracts & Agreements
29 Contracts & Agreements
- Letter Agreement between the Company and David Mark McClung dated November 1, 2021 (Filed With SEC on February 24, 2022)
- Letter Agreement between the Company and (Filed With SEC on November 4, 2021)
- Letter Agreement between the Company and (Filed With SEC on August 5, 2021)
- Letter Agreement between the Company and (Filed With SEC on May 4, 2021)
- Letter Agreement between the Company and (Filed With SEC on May 4, 2021)
- Description of (Filed With SEC on February 24, 2021)
- Letter Agreement dated as of January 22, 2021 between Sangamo Therapeutics, Inc. and Sung Lee (Filed With SEC on January 28, 2021)
- Letter Agreement (Filed With SEC on August 5, 2020)
- Open Market Sale Agreement, dated August 5, 2020, between Sangamo Therapeutics, Inc. and Jefferies LLC (Filed With SEC on August 5, 2020)
- Form of Indemnity Agreement (Filed With SEC on May 11, 2020)
- Description of Securities of the Company (Filed With SEC on February 28, 2020)
- Amendment No. 1 to the Tender Offer Agreement dated October 1, 2018, between the Company and TxCell (Filed With SEC on November 6, 2018)
- Tender Offer Agreement dated July 20, 2018, between the Company and TxCell (Filed With SEC on July 23, 2018)
- Offer Letter between the Company and Curt A. Herberts, dated August 16, 2010 (Filed With SEC on March 1, 2018)
- Exhibit A (Filed With SEC on May 5, 2016)
- NINTH AMENDMENT (Filed With SEC on May 7, 2014)
- *** CONFIDENTIAL PORTIONS OMITTED AND FILED SEPARATELY WITH THE COMMISSION (Filed With SEC on August 5, 2011)
- *** CONFIDENTIAL PORTIONS OMITTED AND FILED SEPARATELY WITH THE COMMISSION (Filed With SEC on August 5, 2011)
- *** CONFIDENTIAL PORTIONS OMITTED AND FILED SEPARATELY WITH THE COMMISSION 2. (Filed With SEC on November 4, 2008)
- *** CONFIDENTIAL PORTIONS OMITTED AND FILED SEPARATELY WITH THE COMMISSION (Filed With SEC on May 9, 2008)
- SANGAMO BIOSCIENCES, INC. (Filed With SEC on December 3, 2007)
- our strategy (Filed With SEC on November 1, 2007)
- Current assets (Filed With SEC on August 9, 2007)
- SANGAMO BIOSCIENCES, INC. 3,000,000 SHARES (Filed With SEC on May 18, 2007)
- our strategy (Filed With SEC on March 1, 2007)
- our strategy (Filed With SEC on March 16, 2006)
- /s/ Dr. Casey Case Dr. Casey Case November 18, 2005 Date (Filed With SEC on November 22, 2005)
- our strategy (Filed With SEC on February 23, 2005)
- THIRDAMENDMENT TO LICENSEAGREEMENT (Filed With SEC on February 24, 2004)